| Literature DB >> 34427226 |
Rachna Agarwal1, Vaibhav K Jain1, Shalini Singh1, Akshata Charlotte1, Vikas Kanaujia1, Prabhakar Mishra2, Kumudini Sharma1.
Abstract
PURPOSE: The aim of this study was to determine the alteration in ganglion cell complex and its relationship with retinal nerve fiber layer (RNFL) thickness as measured by spectral-domain optical coherence tomography (OCT) in pituitary adenoma cases and also its correlation with visual field (VF).Entities:
Keywords: Chiasmal compression; ganglion cell complex thickness; ganglion cell layer-inner plexiform laye; pituitary adenoma; retinal nerve fiber layer; visual field
Mesh:
Year: 2021 PMID: 34427226 PMCID: PMC8544063 DOI: 10.4103/ijo.IJO_2086_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Baseline characteristics of patients with pituitary adenoma and healthy controls
| Characteristics | Study Group (Patients with Pituitary Adenoma) | Control Group |
|
|---|---|---|---|
| No. of Patients | 24 | 24 | |
| No. of Eyes | 24 | 24 | |
| Mean Age (±SD) years | 39.38±14 | 36.46±5.75 | 0.352* |
| Sex Ratio Male/Female | 15/9 | 15/9 | 0.999** |
| Mean Retinal Nerve Fibre Layer thickness (±SD) µ | 84.66±20.83 | 96.16±9.26 | 0.039 |
| Mean Ganglion Cell Layer-Inner Plexiform Layer thickness (±SD) µ | 65.35±18.90 µ | 82.58±3.94 | 0.002* |
| Visual Field mean deviation dB (±SD) | 16.34±7.23 | 1.01±0.88 | <0.001 |
*Independent Sample ‘t’ test; **Chi-square test
Sectoral retinal nerve fibre layer thickness measurements between the study group and control group. B
| Retinal Nerve Fiber Layer thickness | Study Group (Pituitary Adenoma) | Control Group | |
|---|---|---|---|
| Superior (±SD) µ | 105.94±29.90 | 120.29±12.25 | 0.069 |
| Temporal (±SD) µ | 60.94±22.31 | 64.25±10.17 | 0.523 |
| Inferior (±SD) µ | 80.25±54.22 | 124.21±16.97 | 0.001 |
| Nasal (±SD) µ | 48.83±31.89 | 73.71±10.74 | 0.001 |
| Average (±SD) µ | 84.66±20.83 | 96.16±9.26 | 0.039 |
*Independent Sample ‘t’ test
Ganglion cell layer-inner plexiform layer (GCL-IPL) measurements between the study group and control group
| GCL-IPL thickness | Study Group (Pituitary Adenoma) | Control Group | |
|---|---|---|---|
| Superior (±SD) µ | 63.00±21.87 | 83.35±4.03 | 0.001 |
| Inferior (±SD) µ | 64.50±19.05 | 81.65±3.80 | 0.001 |
| Inferotemporal (±SD) µ | 66.00±19.97 | 81.87±4.50 | 0.004 |
| Inferonasal (±SD) µ | 46.71±32.52 | 80.63±17.94 | <0.001 |
| Superotemporal (±SD) µ | 66.39±15.58 | 80.39±4.47 | 0.002 |
| Superonasal (±SD) µ | 49.54±33.58 | 81.79±18.14 | <0.001 |
| Average (±SD) µ | 65.35±18.90 | 82.58±3.94 | 0.002 |
| Minimum (±SD) µ | 38.75±32.48 | 79.96±4.11 | <0.001 |
*Independent Sample ‘t’ test
Figure 1Receiver operating characteristic curve of ganglion cell-inner plexiform layer and retinal nerve fiber layer
The comparison of raw values of visual field mean deviation (MD), Ganglion cell layer-inner plexiform layer (GCL-IPL), retinal nerve fibre layer (RNFL) of five patients before and after 1 year of surgery for pituitary adenoma
| Parameters | Pre-operative | Post-operative | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| Pt 1 | Pt 2 | Pt 3 | Pt 4 | Pt 5 | Pt 1 | Pt 2 | Pt 3 | Pt 4 | Pt 5 | |
| Visual Field MD | ||||||||||
| Right Eye | -2.37 | - | -19.35 | -3.67 | - | -2.06 | - | -12.90 | -1.99 | -18.56 |
| Left Eye | -1.42 | -16.83 | - 14.34 | -3.92 | - | -1.02 | -8.34 | -12.78 | -2.96 | -19.54 |
| GCL-IPL Average | ||||||||||
| Right Eye | 83 | 58 | 76 | 61 | 48 | 81 | 60 | 61 | 60 | 63 |
| Left Eye | 80 | 53 | 79 | 71 | 49 | 82 | 54 | 80 | 71 | 57 |
| RNFL Average | ||||||||||
| Right Eye | 98 | 45 | 116 | 109 | 52 | 104 | 47 | 118 | 110 | 75 |
| Left Eye | 106 | 60 | 110 | 80 | 53 | 106 | 61 | 112 | 81 | 74 |
| RNFL Superior | ||||||||||
| Right Eye | 137 | 54 | 132 | 126 | 60 | 140 | 58 | 136 | 130 | 102 |
| Left Eye | 148 | 72 | 135 | 108 | 58 | 146 | 73 | 138 | 110 | 89 |
| RNFL Inferior | ||||||||||
| Right Eye | 113 | 54 | 170 | 112 | 59 | 122 | 56 | 172 | 112 | 102 |
| Left Eye | 132 | 76 | 153 | 110 | 68 | 136 | 78 | 150 | 110 | 109 |
| RNFL Nasal | ||||||||||
| Right Eye | 81 | 20 | 102 | 60 | 48 | 83 | 20 | 104 | 62 | 45 |
| Left Eye | 80 | 50 | 97 | 56 | 48 | 82 | 50 | 99 | 58 | 54 |
| RNFL Temporal | ||||||||||
| Right Eye | 63 | 54 | 62 | 138 | 41 | 71 | 54 | 62 | 135 | 53 |
| Left Eye | 64 | 40 | 57 | 44 | 40 | 62 | 42 | 60 | 45 | 44 |
Pt: Patient
Figure 2Retinal nerve fiber layer analysis of one (patient 5 in Table 4) of our study patients showing improvement in all parameters (except nasal quadrant in right eye) postoperatively after 1 year of pituitary adenoma surgery. (right: preoperative; left: postoperative scan)
Figure 3Ganglion cell complex analysis of the same patient as in Fig. 2, showing improvement in all parameters after pituitary resection at 1 year of follow-up. (right: preoperative; left: postoperative scan)
Figure 4Visual field of the same patient as in Fig. 2, showing bitemporal hemianopia after 1 year of surgery with the improvement of vision up to 20/40 both eyes. Preoperative visual field could not be performed due to the low visual acuity (<20/200)